Mediclinic International PLC (MDCM.L)
MDCM.L on London Stock Exchange
341.90GBp
23 Jul 2019
341.90GBp
23 Jul 2019
Change (% chg)
-- (--)
-- (--)
Prev Close
341.90
341.90
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
1,148,765
1,148,765
52-wk High
530.60
530.60
52-wk Low
288.30
288.30
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Mar '19 | 1,545.00 | 0.023 |
| Sep | 1,387.00 | -0.228 | |
| FY 2018 | Mar '18 | 1,471.00 | -0.600 |
| Sep | 1,405.00 | -0.068 | |
| FY 2017 | Mar '17 | 1,466.00 | 0.161 |
| Sep | 1,283.00 | 0.149 |
*Note: Units in Millions ofBritish Pounds
**Note: Units in British Pounds
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Mar-19 | 10 | 2,936.92 | 2,981.88 | 2,910.76 | -- |
| Year Ending Mar-20 | 10 | 3,080.84 | 3,125.00 | 3,034.73 | 3,122.29 |
| Year Ending Mar-21 | 11 | 3,202.14 | 3,264.00 | 3,102.00 | 3,275.99 |
| Earnings (per share) | |||||
| Year Ending Mar-19 | 12 | 26.82 | 30.16 | 24.06 | -- |
| Year Ending Mar-20 | 11 | 26.14 | 28.73 | 23.90 | 35.18 |
| Year Ending Mar-21 | 12 | 29.80 | 32.80 | 26.32 | 40.06 |
| LT Growth Rate (%) | 2 | 0.62 | 2.10 | -0.86 | 10.41 |
Sales and Profit Figures in British Pound (GBP);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 22.09 | 27.97 | 32.67 | |
| P/E High - Last 5 Yrs. | -- | 106.09 | 47.29 | |
| P/E Low - Last 5 Yrs. | -- | 20.06 | 23.88 | |
| Beta | 1.03 | 0.62 | 0.89 | |
| Price to Sales (TTM) | 1.84 | 17.61 | 7.92 | |
| Price to Book (MRQ) | 1.24 | 4.19 | 5.39 | |
| Price to Tangible Book (MRQ) | 2.62 | 4.74 | 6.71 | |
| Price to Cash Flow (TTM) | 13.03 | 16.89 | 24.37 | |
| % Owned Institutions | -- | 7.07 | 1.45 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.06 | 1.35 | |
| Dividend Yield - 5 Year Avg | -- | 0.83 | 1.38 | |
| Dividend 5 Year Growth Rate | -- | 10.46 | 4.54 | |
| Payout Ratio(TTM) | 25.43 | 13.27 | 40.25 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 33.64 | 11.87 | 12.24 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 30.47 | 10.24 | 7.74 | |
| Sales - 5 Yr. Growth Rate | -- | 15.24 | 10.88 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 29.83 | 61.98 | 43.01 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 4.44 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 10.35 | 10.32 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 24.44 | 14.84 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.66 | 8.95 | 2.21 |
| Current Ratio (MRQ) | 1.81 | 9.24 | 3.03 |
| LT Debt to Equity (MRQ) | 47.99 | 49.64 | 10.21 |
| Total Debt to Equity (MRQ) | 49.68 | 62.85 | 14.56 |
| Interest Coverage (TTM) | 6.42 | 31.43 | 29.22 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 38.30 | 39.63 | 52.21 | |
| Gross Margin - 5 Yr. Avg. | -- | 40.55 | 50.40 | |
| EBITD Margin (TTM) | 18.52 | -- | -- | |
| EBITD - 5 Yr. Avg | -- | 0.44 | 13.16 | |
| Operating Margin (TTM) | 13.17 | -3.44 | 6.88 | |
| Operating Margin - 5 Yr. Avg. | -- | -10.28 | 8.97 | |
| Pre-Tax Margin (TTM) | 11.17 | 5.84 | 6.08 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | 0.06 | 9.26 | |
| Net Profit Margin (TTM) | 8.84 | 2.96 | 2.72 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -2.51 | 5.63 | |
| Effective Tax Rate (TTM) | 20.85 | 19.56 | 22.40 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 36.11 | 22.74 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 93,364 | 6,595,271 | 887,716,663 | |
| Net Income/Employee (TTM) | 8,253 | -934,615 | 101,894,138 | |
| Receivable Turnover (TTM) | -- | 8.14 | 5.94 | |
| Inventory Turnover (TTM) | -- | 65.06 | 3.36 | |
| Asset Turnover (TTM) | -- | 0.61 | 0.94 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -- | 5.30 | 11.18 | |
| Return on Assets - 5 Yr. Avg. | -- | 5.94 | 12.34 | |
| Return on Investment (TTM) | -- | 6.82 | 14.49 | |
| Return on Investment - 5 Yr. Avg. | -- | 7.52 | 16.03 | |
| Return on Equity (TTM) | -- | 10.85 | 15.79 | |
| Return on Equity - 5 Yr. Avg. | -- | 11.39 | 17.02 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 30.47 | -- | -- |
| EPS (TTM) % | 5.16 | -- | -- |
| Dividend % | 0.00 | -- | -- |
Note: Units in Millions of US Dollars
Performance for Mediclinic International PLC
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -8.41 | -10.29 | 52 | 31 |
| 13 Week | -6.16 | -8.59 | 99 | 36 |
| 26 Week | -1.93 | -4.73 | 99 | 22 |
| 52 Week | -22.83 | -28.81 | 77 | 15 |
| YTD | -11.02 | -16.52 | 95 | 12 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- Ex-divs to take 4.5 points off FTSE 100 on June 13
- Mediclinic core profit falls on Swiss regulatory changes
- UPDATE 1-Mediclinic core profit falls on Swiss regulatory changes
- BRIEF-Mediclinic's Swiss Hospital Operators Have Been Affected By Outpatient Tariff Reductions
- Mediclinic FY core profit falls on Swiss regulatory changes
Institutional Holders
| % Shares Owned: | 40.46% |
| # of Holders: | 211 |
| Total Shares Held: | 298,301,789 |
| 3 Mo. Net Change: | 13,148,199 |
| # New Positions: | 7 |
| # Closed Positions: | 7 |
| # Increased Positions: | 29 |
| # Reduced Positions: | 20 |
| # Net Buyers: | 9 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.